ETV6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.471200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.526400E-02
Normal-vs-Stage2
4.505400E-01
Normal-vs-Stage3
1.408990E-01
Normal-vs-Stage4
8.311600E-01
Stage1-vs-Stage2
1.049570E-01
Stage1-vs-Stage3
9.242200E-01
Stage1-vs-Stage4
2.836400E-02
Stage2-vs-Stage3
1.559240E-01
Stage2-vs-Stage4
4.860400E-01
Stage3-vs-Stage4
1.283010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.913600E-01
Normal-vs-AfricanAmerican
7.361200E-01
Normal-vs-Asian
7.483800E-01
Caucasian-vs-AfricanAmerican
3.484400E-01
Caucasian-vs-Asian
3.115200E-01
AfricanAmerican-vs-Asian
9.253600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.808000E-01
Normal-vs-Female
3.196200E-01
Male-vs-Female
8.968600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.585700E-02
Normal-vs-Age(41-60Yrs)
7.402800E-01
Normal-vs-Age(61-80Yrs)
2.248400E-01
Normal-vs-Age(81-100Yrs)
8.013800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.314030E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.747800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.804200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.060000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.474400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.919600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.208820E-01
Normal-vs-Daily Drinker
1.664360E-01
Normal-vs-Weekly Drinker
4.228600E-01
Normal-vs-Occasional Drinker
7.768800E-01
Normal-vs-Social Drinker
7.795400E-01
Non Drinker-vs-Daily Drinker
8.378000E-01
Non Drinker-vs-Weekly Drinker
4.709200E-01
Non Drinker-vs-Occasional Drinker
1.208800E-01
Non Drinker-vs-Social Drinker
6.062200E-02
Daily Drinker-vs-Weekly Drinker
4.480200E-01
Daily Drinker-vs-Occasional Drinker
1.026770E-01
Daily Drinker-vs-Social Drinker
8.126400E-02
Weekly Drinker-vs-Occasional Drinker
4.555000E-01
Weekly Drinker-vs-Social Drinker
4.038000E-01
Occasional Drinker-vs-Social Drinker
9.502600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.819760E-01
Normal-vs-Grade 2
8.135000E-03
Normal-vs-Grade 3
7.684300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.401800E-02
Grade 1-vs-Grade 3
2.736100E-02
Grade 1-vs-Grade 4
1.819760E-01
Grade 2-vs-Grade 3
3.468000E-01
Grade 2-vs-Grade 4
8.135000E-03
Grade 3-vs-Grade 4
7.684300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.447800E-01
Normal-vs-NonDiabetic
3.678600E-01
Diabetic-vs-NonDiabetic
5.691800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.201600E-01
Normal-vs-NoPancreatitis
2.630800E-01
Pancreatitis-vs-NoPancreatitis
1.957790E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.958180E-01
Normal-vs-N1
4.110600E-01
N0-vs-N1
7.240500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.935200E-01
Normal-vs-TP53-NonMutant
1.178810E-01
TP53-Mutant-vs-TP53-NonMutant
4.194800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
